Digital Pharma: More painful progress for NHS electronic records
May 26, 2011Medical Communications Digital Pharma blog, IT, NHS, electronic patient records
The NHS’ plans for electronic patient records are in tatters, dogged by missed deadlines, poor value for money and a …
Pharma faces ‘trench warfare’ with NHS
May 26, 2011Sales and Marketing Cost cutting, NHS, prescribing
The competing interests of the NHS and the pharma industry could end in trench warfare, a leading NHS figure has …
BMA calls for major amendments to Health Bill
May 26, 2011Health and Social Care Bill, NHS reforms
The BMA says the government should withdraw its plans for health reform completely and go back to the drawing board. …
British biotech: rebuilding momentum
May 26, 2011Research and Development UK, biotech, biotech funding
Since biotech first emerged in the UK in the late 1980s, the dream has always been for the country to …
NICE to appraise hep C drugs Victrelis and telaprevir
May 26, 2011Sales and Marketing Brinavess, Ilaris, NICE, Victrelis, Xarelto, Zytiga, telaprevir
NICE’s next round of drug appraisals is set to include two new hepatitis C drugs – Merck Sharpe and Dohme’s …
GSK’s Trobalt launched in UK
May 25, 2011Sales and Marketing GlaxoSmithKline, Trobalt, epilepsy, retigabine
GSK has launched its new epilepsy treatment Trobalt in the UK. Trobalt (retigabine) is as adjunctive treatment of partial onset …
Elan signs $20m research deal with Proteostasis
May 25, 2011Research and Development Elan, Proteostasis, neurodegenerative diseases
Elan Corporation has signed a deal with US small molecule drug specialist Proteostasis Therapeutics to develop products for conditions such …
Eisai extends neuroscience partnership with UCL
May 25, 2011Research and Development Eisai, UCL, academic alliance, academic research, neurodegenerative diseases
Eisai and University College London are to extend their partnership in neuroscience research. The Japanese company’s Neuroscience Product Creation Unit …
Contract research news in brief
May 25, 2011Research and Development contract research, contract research news
Mergers and acquisitions abound in our latest round-up of contract research sector news, as players try to achieve the global …
Mark Duckham joins Adventis Health
May 25, 2011Medical Communications appointment, medical communications
Adventis Health has appointed Mark Duckham to the newly-created role of client services director. In his new position Mark will …
NICE U-turn on Roche’s MabThera
May 25, 2011Sales and Marketing MabThera, NICE, Roche
NICE has provisionally recommended Roche’s MabThera as a maintenance therapy for blood cancer patients. The new draft guidance backs MabThera’s …
Pfizer will invest $21m in US injectables upgrade
May 25, 2011Manufacturing and Production APIs, Pfizer, pharma manufacturing
Pfizer has announced another upgrade of its sterile injectables plant in Portage, Michigan, earmarking around $21 million for new air …
IPA Best of Health Awards shortlist revealed
May 25, 2011Medical Communications Best of Health, IPA
The short list of agencies selected for this year’s IPA Best of Health Awards has been revealed. The IPA’s awards …
Wainwright Associates offer more Free Pharmacovigilance and Regulatory Affairs Webinars
May 24, 2011Business Services Wainwright Associates; free webinars for Pharmacovigilance and Regulatory Affairs
Following the success of the “The roles and responsibilities of an EEA Qualified Person for Pharmacovigilance (QPPV)” webinar delivered on …
J&J and Vertex’s hep C drug Incivek approved by FDA
May 24, 2011Sales and Marketing FDA, Incivek, Johnson & Johnson, Vertex, hepatitis C, telaprevir
The FDA has approved Johnson & Johnson/Vertex’s new oral hepatitis C drug Incivek. Incivek (telaprevir), a protease inhibitor, is now …
CHMP roundup
May 24, 2011Sales and Marketing CHMP, EMA, Fampyra, Vibativ, Victrelis, Xgeva, Yervoy
The latest products to be recommended for European approval include MSD’s Victrelis, Astellas Pharma Europe’s Vibativ, Amgen Europe’s Xgeva and …
Pfizer and BMS to give Eliquis a rolling launch in Europe
May 24, 2011Sales and Marketing Eliquis, Pfizer, apixaban, atrial fibrillation
Pfizer and Bristol-Myers Squibb are gearing up to give their new oral anticoagulant Eliquis a rolling launch in Europe, starting …
Job cuts at AstraZeneca’s US manufacturing plant
May 24, 2011Manufacturing and Production AstraZeneca, job cuts
AstraZeneca says it will cut around 135 positions at its manufacturing facility in Westborough, Massachusetts, from the end of this …
Interpack 2011: new product showcase
May 24, 2011Manufacturing and Production Interpack, manufacturing and production
This year’s Interpack exhibition in Duesseldorf featured the usual crop of new product launches from processing and packaging equipment suppliers. …
Uptake of pharma chemicals by crops “an environmental concern”
May 24, 2011Manufacturing and Production manufacturing and production, pharma manufacturing
Chemicals which enter the environment in the wastewater of pharmaceutical production facilities can be taken up by crops and other …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
